Fiasp: a new faster ‐acting insulin aspart formulation for diabetes

This article describes its properties, efficacy and adverse effects.

Source: Prescriber - July 31, 2017 Category: Primary Care Authors: Steve Chaplin Tags: New Product Source Type: research